Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells - A potential role in the pathogenesis of proteinuria in diabetic patients

被引:102
作者
Maxhimer, JB
Somenek, M
Rao, G
Pesce, CE
Baldwin, D
Gattuso, P
Schwartz, MM
Lewis, EJ
Prinz, RA
Xu, XL
机构
[1] Rush Univ, Ctr Med, Dept Gen Surg, Chicago, IL 60612 USA
[2] Rush Univ, Ctr Med, Dept Med, Endocrinol Sect, Chicago, IL 60612 USA
[3] Rush Univ, Ctr Med, Dept Pathol, Chicago, IL 60612 USA
[4] Rush Univ, Ctr Med, Nephrol Sect, Chicago, IL 60612 USA
关键词
D O I
10.2337/diabetes.54.7.2172
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The molecular mechanisms of heparan sulfate proteoglycan downregulation in the glomerular basement membrane (GBM) of the kidneys with diabetic nephropathy remain controversial. In the present study, we showed that the expression of heparanase-1 (HPR1), a heparan sulfate-degrading endoglycosidase, was upregulated in the renal epithelial cells in the kidney with diabetic nephropathy. Urinary HPR1 levels were elevated in patients with diabetic nephropathy. In vitro cell culture studies revealed that HPR1 promoter-driven luciferase reporter gene expression, HPR1 mRNA, and protein were upregulated in renal epithelial cells under high glucose conditions. Induction of HPR1 expression by high glucose led to decreased cell surface heparan sulfate expression. HPR1 inhibitors were able to restore cell surface heparan sulfate expression. Functional analysis revealed that renal epithelial cells grown under high glucose conditions resulted in an increase of basement membrane permeability to albumin. Our studies suggest that loss of heparan sulfate in the GBM with diabetic nephropathy is attributable to accelerated heparan sulfate degradation by increased HPR1 expression.
引用
收藏
页码:2172 / 2178
页数:7
相关论文
共 34 条
[1]   ACIDIC AND BASIC FIBROBLAST GROWTH-FACTOR BIND WITH DIFFERING AFFINITY TO THE SAME HEPARAN-SULFATE PROTEOGLYCAN ON BALB/C 3T3 CELLS - IMPLICATIONS FOR POTENTIATION OF GROWTH-FACTOR ACTION BY HEPARIN [J].
BROWN, KJ ;
HENDRY, IA ;
PARISH, CR .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, 58 (01) :6-14
[2]  
COHEN MP, 1981, J LAB CLIN MED, V98, P715
[3]   Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications [J].
Conde-Knape, K .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2001, 17 (06) :412-421
[4]   Heparanase expression in invasive trophoblasts and acute vascular damage [J].
Dempsey, LA ;
Plummer, TB ;
Coombes, SL ;
Platt, JL .
GLYCOBIOLOGY, 2000, 10 (05) :467-475
[5]   Platelet heparanase in vascular responses to xenotransplantation [J].
Dempsey, LA ;
Plummer, TB ;
Coombes, S ;
Platt, JL .
TRANSPLANTATION PROCEEDINGS, 2000, 32 (05) :972-972
[6]  
Elkin M, 2003, CANCER RES, V63, P8821
[7]  
Gambaro G, 1998, AM J PHYSIOL-ENDOC M, V274, pE192, DOI 10.1152/ajpendo.1998.274.1.E192
[8]   CXC CHEMOKINES CONNECTIVE-TISSUE ACTIVATING PEPTIDE-III AND NEUTROPHIL-ACTIVATING PEPTIDE-2 ARE HEPARIN HEPARAN SULFATE-DEGRADING ENZYMES [J].
HOOGEWERF, AJ ;
LEONE, JW ;
REARDON, IM ;
HOWE, WJ ;
ASA, D ;
HEINRIKSON, RL ;
LEDBETTER, SR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (07) :3268-3277
[9]  
Ihrcke NS, 1998, J CELL PHYSIOL, V175, P255, DOI 10.1002/(SICI)1097-4652(199806)175:3<255::AID-JCP3>3.0.CO
[10]  
2-N